Prevalence and risk of depressive disorders in women with polycystic ovary syndrome (PCOS)

Elsenbruch, 2003, Quality of life, psychosocial well-being, and sexual satisfaction in women with polycystic ovary syndrome, J Clin Endocrinol Metab, 88, 5801, 10.1210/jc.2003-030562 McCook, 2005, Health-related quality of life issues in women with polycystic ovary syndrome, J Obstet Gynecol Neonatal Nurs, 34, 12, 10.1177/0884217504272945 Hollinrake, 2007, Increased risk of depressive disorders in women with polycystic ovary syndrome, Fertil Steril, 87, 1369, 10.1016/j.fertnstert.2006.11.039 Spitzer, 2000, Validity and utility of the PRIME-MD patient health questionnaire in assessment of 3000 obstetric-gynecologic patients: the PRIME-MD Patient Health Questionnaire Obstetric-Gynecologic Study, Am J Obstet Gynecol, 183, 759, 10.1067/mob.2000.106580 Kroenke, 2001, The PHQ-9: validity of a brief depression severity measure, J Gen Intern Med, 16, 606, 10.1046/j.1525-1497.2001.016009606.x Spitzer, 1999, Validation and utility of a self-report version of PRIME-MD, JAMA, 282, 1737, 10.1001/jama.282.18.1737 2004, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS), Hum Reprod, 9, 41 Legro, 1999, Prevalence and predictors of risk for Type 2 diabetes mellitus and IGT in polycystic ovary syndrome: a prospective controlled study in 254 affected women, J Clin Endocrinol Metab, 84, 165 Lewis, 2003, Polycystic ovary syndrome: a diagnostic challenge, Infertil Reprod Med Clin North Am, 14, 497 Weiner, 2004, Androgens and mood dysfunction in women: comparison of women with polycystic ovary syndrome to healthy controls, Psychosom Med, 66, 356 Rasgon, 2003, Depression in women with polycystic ovary syndrome: clinical and biochemical correlates, J Affect Disord, 74, 299, 10.1016/S0165-0327(02)00117-9 Weber, 2000, Testosterone, androstenedione and dihydrotestosterone concentrations are elevated in female patients with major depression, Psychoneuroendocrinology, 25, 765, 10.1016/S0306-4530(00)00023-8 Baischer, 1995, Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: elevated blood testosterone concentration compared to normal controls, Psychoneuroendocrinology, 20, 553, 10.1016/0306-4530(94)00081-K Legro, 1998, A fasting glucose to insulin ratio is a useful measure of insulin sensitivity in women with polycystic ovary syndrome, J Clin Endocrinol Metab, 83, 2694 Golomb, 2002, Insulin sensitivity markers: predictors of accidents and suicides in Helsinki Heart Study screenees, J Clin Epidemiol, 55, 767, 10.1016/S0895-4356(02)00407-9 Lawlor, 2003, Association of insulin resistance with depression: cross sectional findings from the British women's heart and health study, BMJ, 327, 1383, 10.1136/bmj.327.7428.1383 Lawlor, 2005, Insulin resistance and depressive symptoms in middle aged men: findings from the Caerphilly Prospective Cohort Study, BMJ, 26, 705, 10.1136/bmj.38377.616921.F7 Majewska, 1990, The neurosteroid dehydroepiandrosterone sulfate is an allosteric antagonist of the GABA-A receptor, Brain Res, 526, 143, 10.1016/0006-8993(90)90261-9 Majewska, 1988, Neurosteroid pregnenolone sulfate antagonizes electrophysiological responses to GABA in neurons, Neurosci Lett, 90, 279, 10.1016/0304-3940(88)90202-9 Takebavashi, 1995, Plasma dehydroepiandrosterone sulfate in unipolar depression, J Neural Transm, 105, 537, 10.1007/s007020050077 Murray, 1996, vol. 1 Douglas, 1995, Statistics notes: Absence of evidence is not evidence of absence, BMJ, 311, 485, 10.1136/bmj.311.7003.485